Search

everythinglearnresearchcommunity

for

Search:↓

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

A man lost all his hair as a rare side effect after hepatitis C treatment.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Stress stops hair growth in mice by causing early hair growth phase end and harmful inflammation through a specific nerve-related pathway.

The document concludes that diagnosing and treating Human African Trypanosomiasis is challenging, but new treatments like fexinidazole are promising.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Imiquimod 5% cream reduced equine sarcoids in most cases.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Exosomes can improve skin health and offer new treatments for skin repair and rejuvenation.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.